First-Line PD-1 Blockade Combined With Chemotherapy for Stage IV Penile Squamous Cell Carcinoma: A Multicenter Retrospective Study
2024 · Journal of the National Comprehensive Cancer Network · 3 citations
https://doi.org/10.6004/jnccn.2024.7074
X
Xingli Shan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
27
Citations
3
h-index
1
i10-index
Xingli Shan is an academic researcher from Cancer Hospital of Huanxing Chaoyang District Beijing. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Urologic and reproductive health conditions & Genital Health and Disease. The author has an h-index of 3, co-authored 11 publications.
Papers by this author
worksAdditional file 2 of Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19720018
Additional file 1 of Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19720015
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat